Cereno Scientific participates at DNB Nordic Healthcare Conference 2024
Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for diseases with high unmet medical needs, today announced that the Company will participate at DNB Nordic Healthcare Conference, in Oslo, November 26, 2024.The in-person event will be held at DNB's Head office in Oslo, and will include a full day of presentations, investor meetings, networking and more. Sten R. Sörensen, CEO, will hold a company presentation of Cereno as well as take part in meetings with investors. More information about the event can be found here https://www.meetmax.